These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Risk score for predicting death, myocardial infarction, and stroke in patients with stable angina, based on a large randomised trial cohort of patients. Clayton TC; Lubsen J; Pocock SJ; Vokó Z; Kirwan BA; Fox KA; Poole-Wilson PA BMJ; 2005 Oct; 331(7521):869. PubMed ID: 16210253 [TBL] [Abstract][Full Text] [Related]
66. [Nifedipine in ischemic heart disease: a ban on its use or a differential approach to therapy?]. Martsevich SIu Ter Arkh; 1996; 68(9):31-5. PubMed ID: 9005608 [TBL] [Abstract][Full Text] [Related]
67. Effects of long-acting versus short-acting calcium channel blockers among older survivors of acute myocardial infarction. Gillman MW; Ross-Degnan D; McLaughlin TJ; Gao X; Spiegelman D; Hertzmark E; Goldman L; Soumerai SB J Am Geriatr Soc; 1999 May; 47(5):512-7. PubMed ID: 10323641 [TBL] [Abstract][Full Text] [Related]
68. Myocardial infarction associated with the administration of intravenous ephedrine and metaraminol for spinal-induced hypotension. Khavandi A; Gatward JJ; Whitaker J; Walker P Anaesthesia; 2009 May; 64(5):563-6. PubMed ID: 19413828 [TBL] [Abstract][Full Text] [Related]
69. Assessment of cocaine use in patients with chest pain syndromes. Hollander JE; Brooks DE; Valentine SM Arch Intern Med; 1998 Jan; 158(1):62-6. PubMed ID: 9437380 [TBL] [Abstract][Full Text] [Related]
70. Angina and myocardial infarction with use of leuprolide acetate. McCoy MJ Am J Obstet Gynecol; 1994 Jul; 171(1):275-6. PubMed ID: 8030717 [TBL] [Abstract][Full Text] [Related]
71. FDA gives calcium channel blockers clean bill of health but warns of short-acting nifedipine hazards. Marwick C JAMA; 1996 Feb; 275(6):423-4. PubMed ID: 8627948 [No Abstract] [Full Text] [Related]
72. Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985 to 1993. Koenig W; Löwel H; Lewis M; Hörmann A Eur Heart J; 1996 Aug; 17(8):1199-206. PubMed ID: 8869861 [TBL] [Abstract][Full Text] [Related]
73. [Use of beta-blockers and a calcium antagonist in angina pectoris during the period of postinfarct rehabilitation]. Urbaniuk KG; Mazurets AF; Volgina AS Klin Med (Mosk); 1984 Jul; 62(7):36-9. PubMed ID: 6548272 [No Abstract] [Full Text] [Related]
74. Safety of nifedipine in angina pectoris: a meta-analysis. Stason WB; Schmid CH; Niedzwiecki D; Whiting GW; Caubet JF; Cory D; Luo D; Ross SD; Chalmers TC Hypertension; 1999 Jan; 33(1):24-31. PubMed ID: 9931077 [TBL] [Abstract][Full Text] [Related]
75. Calcium channel blockers for hypertension: dissecting the evidence for adverse effects. Opie LH Am J Hypertens; 1997 May; 10(5 Pt 1):565-77. PubMed ID: 9160770 [TBL] [Abstract][Full Text] [Related]
77. Postmarketing study of cardiovascular adverse reactions associated with sumatriptan. Ottervanger JP; van Witsen TB; Valkenburg HA; Stricker BH BMJ; 1993 Nov; 307(6913):1185. PubMed ID: 8251846 [No Abstract] [Full Text] [Related]
78. Myocardial infarction associated with pseudoephedrine use and acute streptococcal infection in a boy with normal coronary arteries. Biyik I; Ergene O Can J Cardiol; 2006 Mar; 22(3):254-6. PubMed ID: 16520858 [TBL] [Abstract][Full Text] [Related]
79. Aggravation of myocardial ischaemia by nifedipine. Sia ST; MacDonald PS; Triester B; Oliver LE; Horowitz JD; Goble AJ Med J Aust; 1985 Jan; 142(1):48-50. PubMed ID: 3965875 [TBL] [Abstract][Full Text] [Related]
80. What does Cave JA; Phizackerley D Drug Ther Bull; 2023 May; 61(5):66. PubMed ID: 37116907 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]